✦ LIBER ✦

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

✍ Scribed by Mahaffey, K. W.; Stevens, S. R.; White, H. D.; Nessel, C. C.; Goodman, S. G.; Piccini, J. P.; Patel, M. R.; Becker, R. C.; Halperin, J. L.; Hacke, W.; Singer, D. E.; Hankey, G. J.; Califf, R. M.; Fox, K. A. A.; Breithardt, G.

Book ID: 125467082
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 369 KB
Volume: 35
Category: Article
ISSN: 0195-668X
DOI: 10.1093/eurheartj/eht428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivaroxaban—Once daily, oral, direct fac

Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Use and outcomes of antiarrhythmic thera

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: Results from the ROCKET AF trial

✍ Steinberg, Benjamin A.; Hellkamp, Anne S.; Lokhnygina, Yuliya; Halperin, Jonatha 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 615 KB

USE AND OUTCOMES OF ANTIARRHYTHMIC THERA

USE AND OUTCOMES OF ANTIARRHYTHMIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING ORAL ANTICOAGULATION: RESULTS FROM THE ROCKET AF TRIAL

✍ Steinberg, Benjamin; Hellkamp, Anne; Lokhnygina, Yuliya; Halperin, Jonathan; Bre 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Intracranial Hemorrhage Among Patients W

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation

✍ Hankey, G. J.; Stevens, S. R.; Piccini, J. P.; Lokhnygina, Y.; Mahaffey, K. W.; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 920 KB

Letter by Apostolakis et al Regarding Ar

Letter by Apostolakis et al Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

✍ Apostolakis, Stavros ;Lane, Deirdre A. ;Banerjee, Amitava 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 419 KB